4.1 Review

Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination

期刊

EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 10, 期 3, 页码 441-457

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.10.13

关键词

apoptosis; blood-brain barrier; demyelination; inflammation; multiple sclerosis; remyelination strategies

资金

  1. NIH [NS RO1 32129, NS RO1 507 24180]
  2. National Multiple Sclerosis Society [R63172, CA 1011A8]
  3. Multiple Sclerosis Research Foundation of Canada [CMS-05]
  4. Applebaum and Hilton Foundations
  5. Minnesota Partnership Award for Biotechnology and Medical Genomics
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024180, R01NS032129] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS. A better understanding of why remyelination fails in MS is necessary to improve remyelination strategies. Remyelination is mediated by oligodendrocyte precursor cells (OPCs), which are widely distributed throughout the adult CNS. However, it is still unclear whether OPCs detectable in MS lesions survive the inflammatory response but are unable to myelinate or whether OPC and oligodendrocyte death is primarily responsible for remyelination failure and detectable OPCs enter demyelinated areas from adjacent tissue as the lesion evolves. Remyelination strategies should, therefore, focus on stimulation of differentiation or prevention of apoptosis, as well as establishment of a supportive environment for OPC-mediated remyelination, which may be especially important in chronically demyelinated lesions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据